Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Prolactin for Lactation Induction
NCT00181610Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Sep 2004
- Primary completion
- Sep 2010
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of recombinant human prolactin in lactation insufficiency (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Change in Breast Milk Volume Baseline to 7 Days. Started Sep 2004; status: completed.
02
Drugs
recombinant human prolactin
03
Conditions
lactation insufficiency
Beyond the preview
Go deeper on NCT00181610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181610.